917TiPPhase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations. (23rd October 2018) - Rodríguez-Vida, A; Pérez-Gracia, J L; Taus, A; Bonfill, T; Vázquez-Mazón, F J; Galtes, S; Pons, B; Cano, L; Macia, S; Maroto, P; Bellmunt, J